Oui, les groupes de soutien offrent un environnement d'encouragement et de partage d'expériences.
Groupes de soutienIntervention sociale
#5
Combien de temps dure un traitement pour le tabagisme ?
La durée du traitement varie, mais il est souvent recommandé de suivre un programme de plusieurs mois.
Durée du traitementPlan de traitement
Complications
5
#1
Quelles sont les complications du tabagisme ?
Les complications incluent des maladies cardiovasculaires, des cancers et des maladies respiratoires.
Maladies cardiovasculairesCancers
#2
Le tabagisme affecte-t-il la santé mentale ?
Oui, il est associé à des troubles de l'humeur, de l'anxiété et des problèmes de dépendance.
Santé mentaleTroubles de l'humeur
#3
Le tabagisme peut-il entraîner des problèmes de fertilité ?
Oui, il peut réduire la fertilité chez les hommes et les femmes, affectant la reproduction.
FertilitéSanté reproductive
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec l'arrêt du tabac, mais pas toutes.
RéversibilitéArrêt du tabac
#5
Le tabagisme augmente-t-il le risque d'infections ?
Oui, il affaiblit le système immunitaire, augmentant le risque d'infections respiratoires.
Infections respiratoiresSystème immunitaire
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du tabagisme ?
Les facteurs incluent l'exposition à la fumée, l'hérédité et des influences sociales.
Facteurs de risqueExposition à la fumée
#2
L'âge influence-t-il le risque de tabagisme ?
Oui, les jeunes adultes sont plus susceptibles de commencer à fumer en raison de la pression sociale.
ÂgePression sociale
#3
Le stress est-il un facteur de risque ?
Oui, le stress peut inciter à fumer comme moyen de gestion des émotions et de l'anxiété.
StressGestion des émotions
#4
Les antécédents familiaux jouent-ils un rôle ?
Oui, avoir des membres de la famille fumeurs augmente le risque de développer une dépendance.
Antécédents familiauxDépendance au tabac
#5
Les publicités influencent-elles le tabagisme ?
Oui, les publicités peuvent normaliser le tabagisme et inciter les jeunes à commencer à fumer.
PublicitéInfluence sociale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Trouble lié au tabagisme : Questions médicales les plus fréquentes",
"headline": "Trouble lié au tabagisme : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Trouble lié au tabagisme : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-31",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Trouble lié au tabagisme"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles liés à une substance",
"url": "https://questionsmedicales.fr/mesh/D019966",
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés à une substance",
"code": {
"@type": "MedicalCode",
"code": "D019966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Trouble lié au tabagisme",
"alternateName": "Tobacco Use Disorder",
"code": {
"@type": "MedicalCode",
"code": "D014029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joseph Guydish",
"url": "https://questionsmedicales.fr/author/Joseph%20Guydish",
"affiliation": {
"@type": "Organization",
"name": "Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: joseph.guydish@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Thao Le",
"url": "https://questionsmedicales.fr/author/Thao%20Le",
"affiliation": {
"@type": "Organization",
"name": "Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: thao.le@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Kevin Delucchi",
"url": "https://questionsmedicales.fr/author/Kevin%20Delucchi",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, University of California San Francisco, 401 Parnassus Ave., San Francisco, CA 94143, United States of America. Electronic address: kevin.delucchi@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Guang-Heng Dong",
"url": "https://questionsmedicales.fr/author/Guang-Heng%20Dong",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Yunnan Normal University, Kunming, Yunnan Province, PR China. Electronic address: dongguangheng@ynnu.edu.cn."
}
},
{
"@type": "Person",
"name": "Caravella McCuistian",
"url": "https://questionsmedicales.fr/author/Caravella%20McCuistian",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Behavioral Sciences, University of California, San Francisco 1001 Potrero Ave, San Francisco, CA 94110, United States. Electronic address: caravella.mccuistian@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of Myopia: Prevalence, Risk Factors and Effects of Myopia.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384213",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2340-1790"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of myopia-associated genes in a Han Chinese population with high myopia.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37165999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2023.2191709"
}
},
{
"@type": "ScholarlyArticle",
"name": "Extreme myopia is more susceptible to SOX2 gene than high myopia.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36921835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exer.2023.109435"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of myopia and uncorrected myopia among 721 032 schoolchildren in a city-wide vision screening in southern China: the Shantou Myopia Study.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/36198476",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2021-320940"
}
},
{
"@type": "ScholarlyArticle",
"name": "EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36708714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17434440.2023.2174429"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles liés à une substance",
"item": "https://questionsmedicales.fr/mesh/D019966"
},
{
"@type": "ListItem",
"position": 4,
"name": "Trouble lié au tabagisme",
"item": "https://questionsmedicales.fr/mesh/D014029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Trouble lié au tabagisme - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Trouble lié au tabagisme",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Trouble lié au tabagisme",
"description": "Comment diagnostiquer un trouble lié au tabagisme ?\nQuels critères sont utilisés pour le diagnostic ?\nQui peut poser le diagnostic ?\nY a-t-il des tests spécifiques pour le diagnostic ?\nLe diagnostic peut-il être fait à distance ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Myopia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Trouble lié au tabagisme",
"description": "Quels sont les symptômes du trouble lié au tabagisme ?\nComment se manifeste le sevrage tabagique ?\nLe tabagisme peut-il affecter l'humeur ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Myopia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Trouble lié au tabagisme",
"description": "Comment prévenir le trouble lié au tabagisme ?\nLes campagnes anti-tabac sont-elles efficaces ?\nQuel rôle jouent les écoles dans la prévention ?\nLes lois anti-tabac aident-elles à réduire la consommation ?\nLes programmes de cessation sont-ils accessibles ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Myopia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Trouble lié au tabagisme",
"description": "Quels traitements sont disponibles pour le tabagisme ?\nLes médicaments sont-ils efficaces contre le tabagisme ?\nQu'est-ce que la thérapie comportementale ?\nLes groupes de soutien sont-ils utiles ?\nCombien de temps dure un traitement pour le tabagisme ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Myopia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Trouble lié au tabagisme",
"description": "Quelles sont les complications du tabagisme ?\nLe tabagisme affecte-t-il la santé mentale ?\nLe tabagisme peut-il entraîner des problèmes de fertilité ?\nLes complications sont-elles réversibles ?\nLe tabagisme augmente-t-il le risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Myopia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Trouble lié au tabagisme",
"description": "Quels sont les principaux facteurs de risque du tabagisme ?\nL'âge influence-t-il le risque de tabagisme ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes publicités influencent-elles le tabagisme ?",
"url": "https://questionsmedicales.fr/mesh/D014029?mesh_terms=Myopia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble lié au tabagisme ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de dépendance."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la consommation régulière, le désir de réduire et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé, comme un médecin ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests spécifiques pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de tests spécifiques, le diagnostic est basé sur l'entretien clinique."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être fait à distance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations en ligne peuvent permettre d'évaluer les habitudes de consommation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du trouble lié au tabagisme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent le besoin urgent de fumer, l'irritabilité et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage tabagique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer anxiété, dépression, troubles du sommeil et fringales."
}
},
{
"@type": "Question",
"name": "Le tabagisme peut-il affecter l'humeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut entraîner des fluctuations d'humeur et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la toux, l'essoufflement et des douleurs thoraciques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la durée et de l'intensité de la consommation."
}
},
{
"@type": "Question",
"name": "Comment prévenir le trouble lié au tabagisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et des politiques anti-tabac efficaces."
}
},
{
"@type": "Question",
"name": "Les campagnes anti-tabac sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sensibilisent le public aux dangers du tabagisme et encouragent l'arrêt."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les écoles dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les écoles peuvent éduquer les jeunes sur les dangers du tabac et promouvoir des modes de vie sains."
}
},
{
"@type": "Question",
"name": "Les lois anti-tabac aident-elles à réduire la consommation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lois strictes sur la vente et la consommation de tabac réduisent son usage."
}
},
{
"@type": "Question",
"name": "Les programmes de cessation sont-ils accessibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux programmes de cessation sont disponibles dans les centres de santé et en ligne."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le tabagisme ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils efficaces contre le tabagisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme la varénicline et le bupropion sont efficaces pour réduire le besoin de fumer."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie comportementale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une approche qui aide à modifier les comportements liés à la consommation de tabac."
}
},
{
"@type": "Question",
"name": "Les groupes de soutien sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les groupes de soutien offrent un environnement d'encouragement et de partage d'expériences."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement pour le tabagisme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais il est souvent recommandé de suivre un programme de plusieurs mois."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du tabagisme ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des cancers et des maladies respiratoires."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est associé à des troubles de l'humeur, de l'anxiété et des problèmes de dépendance."
}
},
{
"@type": "Question",
"name": "Le tabagisme peut-il entraîner des problèmes de fertilité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut réduire la fertilité chez les hommes et les femmes, affectant la reproduction."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec l'arrêt du tabac, mais pas toutes."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque d'infections ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il affaiblit le système immunitaire, augmentant le risque d'infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du tabagisme ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à la fumée, l'hérédité et des influences sociales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de tabagisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes sont plus susceptibles de commencer à fumer en raison de la pression sociale."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut inciter à fumer comme moyen de gestion des émotions et de l'anxiété."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille fumeurs augmente le risque de développer une dépendance."
}
},
{
"@type": "Question",
"name": "Les publicités influencent-elles le tabagisme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les publicités peuvent normaliser le tabagisme et inciter les jeunes à commencer à fumer."
}
}
]
}
]
}
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: joseph.guydish@ucsf.edu.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States of America. Electronic address: thao.le@ucsf.edu.
Department of Psychiatry, University of California San Francisco, 401 Parnassus Ave., San Francisco, CA 94143, United States of America. Electronic address: kevin.delucchi@ucsf.edu.
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco 1001 Potrero Ave, San Francisco, CA 94110, United States. Electronic address: caravella.mccuistian@ucsf.edu.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA, 94118, United States. Electronic address: kwinoja.kapiteni@ucsf.edu.
OHSU/PSU School of Public Health, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, United States. Electronic address: drbarbaracampbell@earthlink.net.
Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan; School of Nursing, University of Michigan, Ann Arbor, Michigan.
Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan; School of Nursing, University of Michigan, Ann Arbor, Michigan; Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Myopia is the most common cause of visual impairment in children and young adults. In order to assess the consequences for society, it is necessary to know temporal trends in prevalence, incidence and...
High myopia is a leading cause of blindness worldwide. However, the exact etiology and mechanism of high myopia remain unclear. Previous genome-wide association study has demonstrated that nine single...
Seven SNPs were genotyped by the MassARRAY iPLEX Gold method in a Han Chinese cohort with the majority from Henan region (central China), which included 361 patients with high myopia and 749 healthy c...
In terms of genotyped SNPs, the allele frequency of rs698047 locus of the HIVEP3 gene were statistically different between myopia and control groups initially, but the difference disappeared after Bon...
There was no demonstrated association between the occurrence of high myopia in the Chinese Han population and polymorphisms in the following loci: HIVEP3 (rs698047), NFASC/CNTN2 (rs2246661), ZC3H11B (...
To explore the association between two single-nucleotide polymorphisms (SNPs) in the SOX2 gene and high and extreme myopia in the Han Chinese population....
A genetic association study using a case-control method was performed with 139 high myopia, 318 extreme myopia, and 918 healthy participants from the Chinese Han population. Two SNPs (rs4459940 and rs...
The mean ages of the extreme myopia and control subjects were 47.44 ± 15.59 and 44.15 ± 14.08 years, respectively. The rs4575941 SNP of the SOX2 gene and the GG and AG genotypes showed no significant ...
The SOX2 rs4575941 polymorphism, in Chinese Han population, contributes to the susceptibility of extreme myopia. SOX2 may thus be implicated in extreme myopia rather than in high myopia....
To explore the prevalence and risk factors for myopia and uncorrected myopia in schoolchildren in southern China....
The government-led Shantou Myopia Study was conducted from September 2020 to June 2021. Non-cycloplegic refraction was performed. Uncorrected visual acuity (UCVA) was measured along with presenting vi...
This study enrolled 724 828 schoolchildren (77.8% of all schoolchildren in Shantou) from 901 schools. Data from 721 032 schoolchildren (99.5%) were analysed (mean age 11.53±3.13 years, 6-20 years, 373...
The overall prevalence of myopia among schoolchildren in Shantou was 51.8%, higher than the national average in China. The proportion of uncorrected myopia is high, especially in primary schools. Our ...
Intraocular lens implantation in phakic eyes for the correction of refractive error is currently a widespread procedure. The EVO and EVO+ Visian Implantable Collamer Lenses (ICL) are two of the most p...
During the last decade, more than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published. This review describes the objective visual performance achieved with the i...
Refractive surgeons and candidates to undergo ICL implantation should be aware of the excellent safety and visual outcomes provided by the implantation of central hole ICL lenses. However, future rese...
Initial studies have suggested that multiple segment (MS) spectacle lenses can reduce the progression rate of childhood myopia and axial eye growth. This paper aimed to compare the effectiveness of tw...
Published data from the only two clinical trials in which changes in mean spherical equivalent refraction (SER) and axial length (AL) for matched groups of myopic children wearing either MS or single-...
Absolute changes in SER and AL differed over time during the two trials. However, if the results were expressed in terms of efficacy over successive 6-month periods, then the two MS lenses produced br...
Myopia control may be due to either the additional myopic defocus induced by the MS lenses (i.e., asymmetry of the through-focus image changes about the distance focus) or to the general reduction in ...
Multiple segment spectacle lenses offer a valuable new approach to the control of myopia progression in children. Further work is required to clarify their mechanism of action and to optimise their de...
This study is a retrospective analysis to compare ocular biometry measurements of axial length in children with myopia using Myopia Master (OCULUS, Wetzlar, Germany) and Lenstar LS900 (HAAG-STREIT AG,...
Axial length measurements obtained with both instruments within a 3-week period were collected retrospectively. Measurements were visualized with a Bland-Altman plot. For statistical evaluation, a pai...
Sixty-one eyes from 31 myopic patients (59% male, 41% female) with a mean age of 11.34 ± 3.25 years (range: 6 - 18 years) were identified. Mean axial length was 24.7 mm (SD 1.29) with the Myopia Maste...
The axial length measured by Myopia Master and Lenstar LS900 did not differ significantly. Thus, previous values obtained with the Lenstar LS900 can be applied to assess myopia progression....
The META-Analysis of Pathologic Myopia Study group proposed a new classification system for myopic maculopathy (MM) with pathologic myopia (PM) defined as MM equal to/more serious than diffuse atrophy...
This study examined the optical impact of a DF contact lens during near viewing in a sample of habitual DF lens wearing children....
Seventeen myopic children aged 14 to 18 years who had completed 3 or 6 years of treatment with a DF contact lens (MiSight 1 Day; CooperVision, Inc., San Ramon, CA) were recruited and fit bilaterally w...
During near viewing, children wearing single-vision lenses accommodated on average to achieve approximate focus in the pupil center but, because of combined accommodative lag and negative spherical ab...
The DF contact lens did not alter the accommodative behavior of children. The treatment optics introduced myopic defocus and decreased the amount of hyperopically defocused light in the retinal image....
The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approa...